| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 146,556 | 123,288 | 114,426 | 144,493 | | Cost of Revenue | (8,789) | 8,789 | (404,920) | 376,890 | | | Gross Profit | 155,345 | 114,499 | 519,346 | (232,397) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 147,493 | 118,439 | 521,586 | (240,908) | | Non Recurring | 2,774 | 18,183 | 25,070 | 16,845 | | Others | 2,860 | 2,829 | 2,946 | 2,924 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,218 | (24,952) | (30,256) | (11,258) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,439 | 4,733 | 2,903 | (14,794) | | Earnings Before Interest And Taxes | 4,657 | (20,219) | (27,353) | (26,052) | | Interest Expense | 1,259 | 1,442 | 1,839 | 1,267 | | Income Before Tax | 3,398 | (21,661) | (29,192) | (27,319) | | Income Tax Expense | 879 | (7,365) | (11,943) | (4,549) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,745 | (14,273) | (17,200) | (22,356) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,745 | (14,273) | (17,200) | (22,356) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,745 | ($14,273) | ($17,200) | ($22,356) |
|
0.04% Nasdaq 
0.02 (0.12%) 
Income Statement
